首页> 外国专利> 4-H-SUBSTITUTED CHROME AND ANALAGOS AS CASPASE ACTIVATORS AND INDUCTORS OF APOPTOSIS AND USE AS ANTICANCERIGEN AGENTS.

4-H-SUBSTITUTED CHROME AND ANALAGOS AS CASPASE ACTIVATORS AND INDUCTORS OF APOPTOSIS AND USE AS ANTICANCERIGEN AGENTS.

机译:4-H取代的铬和纳那古斯作为胱天蛋白酶激活剂和细胞凋亡诱导剂,并用作抗癌剂。

摘要

Use of a compound selected from the group consisting of: 2-Amino-3-cyano-7-ethylamino-4- (3-bromophenyl) -4H-chromene; 2-Amino-3-cyano-7-ethylamino-4- (3-chlorophenyl) -4H-chromene; 2-Amino-3-cyano-7-ethylamino-4- (3-nitrophenyl) -4H-chromene; 2-Amino-3-cyano-7-ethylamino-4- (3,4,5-trimethoxyphenyl) -4H-chromene; 2-Amino-3-cyano-7-ethylamino-4- (3,5-dimethoxyphenyl) -4H-chromene; 2-Amino-3-cyano-7-ethylamino-4- (3-methoxyphenyl) -4H-chromene; 2-Amino-3-cyano-7-ethylamino-4- (3-cyanophenyl) -4H-chromene; 2-Amino-3-cyano-7-methoxy-4- (3-pyridyl) -4H-chromene; 2-Amino-3-cyano-4- (3-pyridyl) -4H-indole [4,5-b] pyran; 2,7-Diamino-3-cyano-4- (3-bromophenyl) -4H-chromene; 2,7-Diamino-3-cyano-4- (3-cyanophenyl) -4H-chromene; 2,7-Diamino-3-cyano-4- (3-methoxyphenyl) -4H-chromene; 2,7-Diamino-3-cyano-4- (3-chlorophenyl) -4H-chromene; 2,7-Diamino-3-cyano-4- (3-methylphenyl) -4H-chromene; 2,7-Diamino-3-cyano-4- (3-pyridyl) -4H-chromene; 2-Amino-3-cyano-7-methoxy-4- (2,4-dimethoxypyrimidinyl) -4H-chromene; 2-Amino-3-cyano-7-methoxy-4- (1,2,3,6-tetrahydrophenyl) -4H-chromene; 2-Amino-3-cyano-4- (5-bromo-3-pyridyl) -7-ethylamino-4H-chromene; 2,7-Diamino-3-cyano-4- (5-methyl-3-pyridyl) -4H-chromene; 2-Amino-3-cyano-4- (5-methyl-3-pyridyl) -4H-indole [4,5-b] pyran; 2-Amino-3-cyano-4- (5-bromo-3-pyridyl) -4H-indole [4,5-b] pyran; 2,7-Diamino-3-cyano-4- (5-bromo-3-pyridyl) -4H-chromene; 2,7-Diamino-3-cyano-4- (5-methoxy-3-pyridyl) -4H-chromene; 2-Amino-3-cyano-4- (5-methoxy-3-pyridyl) -4H-indole [4,5-b] pyran; 2-Amino-3-cyano-4- (3-bromo-4,5-dimethoxyphenyl) -4H-indole [7,6-b] pyran; 2-Amino-3-cyano-4- (3-methoxyphenyl) -4H-indole [7,6-b] pyran; 3-Cyano-2,7,8-triamino-4- (3-methoxyphenyl) -4H-chromene; 3-Cyano-2,7,8-triamino-4- (3-bromo-4,5-dimethoxyphenyl) -4H-chromene; 2-Amino-3-cyano-4- (3-methoxyphenyl) -4H-indole [4,5-b] pyran; 2-Amino-3-cyano-4- (3,5-dimethoxyphenyl) -4H-indole [7,6-b] pyran; 2-Amino-3-cyano-4- (3-bromo-4,5-dimethoxyphenyl) -4H-imidazo [4,5-h] chromene; 2-Amino-3-cyano-4- (3,4,5-trimethoxyphenyl) -4H-indole [7,6-b] pyran; 2-Amino-3-cyano-7,8-methylenedioxy-4- (3-bromo-4,5-dimethoxyphenyl) -4H-chromene; 2-Amino-3-cyano-7,8-methylenedioxy-4- (3-methoxyphenyl) -4H-chromene; 2-Amino-3-cyano-4- (3-methoxyphenyl) -4H-imidazo [4,5-h] chromene; 2-Amino-3-cyano-4- (3-bromo-4,5-dimethoxyphenyl) -4H-furo [2,3-h] chromene; 2-Amino-3-cyano-4- (3-methoxyphenyl) -4H-furo [2,3-h] chromene; 2-Amino-3-cyano-4- (3-bromo-4,5-dimethoxyphenyl) -4H-thieno [2,3-h] chromene; 2-Amino-3-cyano-4- (3-methoxyphenyl) -4H-pyrazo [2,3-h] chromene; 2-Amino-3-cyano-4- (3-bromo-4,5-dimethoxyphenyl) -4 H -pyrazo [2,3-h] chromene; 2,7-Diamino-3-cyano-4- (3-iodophenyl) -4H-chromene; 2,7-Diamino-3-cyano-4- (3,4,5-trimethoxyphenyl) -4H-chromene; 2-Amino-3-cyano-7-hydroxy-4- (3,4,5-trimethoxyphenyl) -4H-chromene; 2-Amino-3-cyano-7- (2-methylbutanoylamino) -4- (3-bromo-4,5-dimethoxyphenyl) -4H-chromene; 2-Amino-3-cyano-7-dimethylamino-4- (3- (2-phenylbutanoyloxy) phenyl) -4H-chromene; 2-Amino-3-cyano-7-dimethylamino-4- (3- (2-methylbutanoyloxy) phenyl) -4H-chromene; and 2-Amino-3-cyano-4- (3-bromo-4,5-dimethoxyphenyl) -4H-chromene; or one of its pharmaceutically acceptable salts or prodrugs, to prepare a medicament for the treatment of a disorder sensitive to the induction of apoptosis in an animal suffering from it; wherein said prodrug is: a) an ester of a hydroxy-containing compound obtained by condensation with a C1-4 carboxylic acid, C3-6 dioic acid or anhydride thereof; b) an imine of an amino-containing compound, obtained by condensation of an aldehyde or C1-4 ketone; c) a carbamate of an amino-containing compound; d) an acetal or ketal of an alcohol-containing compound, obtained by condensation with a chloromethyl and methyl ether or chloromethyl and ethyl ether; or e) a phosphonate or phosphono compound obtained by condensation with a phosphate ester, phosphoryl chloride or phosphoric acid.
机译:使用选自以下的化合物:2-氨基-3-氰基-7-乙基氨基-4-(3-溴苯基)-4H-色烯; 2-氨基-3-氰基-7-乙基氨基-4-(3-氯苯基)-4H-色烯; 2-氨基-3-氰基-7-乙基氨基-4-(3-硝基苯基)-4H-色烯; 2-氨基-3-氰基-7-乙基氨基-4-(3,4,5-三甲氧基苯基)-4H-色烯; 2-氨基-3-氰基-7-乙基氨基-4-(3,5-二甲氧基苯基)-4H-色烯; 2-氨基-3-氰基-7-乙基氨基-4-(3-甲氧基苯基)-4H-色烯; 2-氨基-3-氰基-7-乙基氨基-4-(3-氰基苯基)-4H-色烯; 2-氨基-3-氰基-7-甲氧基-4-(3-吡啶基)-4H-色烯; 2-氨基-3-氰基-4-(3-吡啶基)-4H-吲哚[4,5-b]吡喃; 2,7-二氨基-3-氰基-4-(3-溴苯基)-4H-色烯; 2,7-二氨基-3-氰基-4-(3-氰基苯基)-4H-色烯; 2,7-二氨基-3-氰基-4-(3-甲氧基苯基)-4H-色烯; 2,7-二氨基-3-氰基-4-(3-氯苯基)-4H-色烯; 2,7-二氨基-3-氰基-4-(3-甲基苯基)-4H-色烯; 2,7-二氨基-3-氰基-4-(3-吡啶基)-4H-色烯; 2-氨基-3-氰基-7-甲氧基-4-(2,4-二甲氧基嘧啶基)-4H-色烯; 2-氨基-3-氰基-7-甲氧基-4-(1,2,3,6-四氢苯基)-4H-色烯; 2-氨基-3-氰基-4-(5-溴-3-吡啶基)-7-乙基氨基-4H-色烯; 2,7-二氨基-3-氰基-4-(5-甲基-3-吡啶基)-4H-色烯; 2-氨基-3-氰基-4-(5-甲基-3-吡啶基)-4H-吲哚[4,5-b]吡喃; 2-氨基-3-氰基-4-(5-溴-3-吡啶基)-4H-吲哚[4,5-b]吡喃; 2,7-二氨基-3-氰基-4-(5-溴-3-吡啶基)-4H-色烯; 2,7-二氨基-3-氰基-4-(5-甲氧基-3-吡啶基)-4H-色烯; 2-氨基-3-氰基-4-(5-甲氧基-3-吡啶基)-4H-吲哚[4,5-b]吡喃; 2-氨基-3-氰基-4-(3-溴-4,5-二甲氧基苯基)-4H-吲哚[7,6-b]吡喃; 2-氨基-3-氰基-4-(3-甲氧基苯基)-4H-吲哚[7,6-b]吡喃; 3-氰基-2,7,8-三氨基-4-(3-甲氧基苯基)-4H-色烯; 3-氰基-2,7,8-三氨基-4-(3-溴-4,5-二甲氧基苯基)-4H-色烯; 2-氨基-3-氰基-4-(3-甲氧基苯基)-4H-吲哚[4,5-b]吡喃; 2-氨基-3-氰基-4-(3,5-二甲氧基苯基)-4H-吲哚[7,6-b]吡喃; 2-氨基-3-氰基-4-(3-溴-4,5-二甲氧基苯基)-4H-咪唑并[4,5-h]色烯; 2-氨基-3-氰基-4-(3,4,5-三甲氧基苯基)-4H-吲哚[7,6-b]吡喃; 2-氨基-3-氰基-7,8-亚甲基二氧基-4-(3-溴-4,5-二甲氧基苯基)-4H-亚甲基; 2-氨基-3-氰基-7,8-亚甲基二氧基-4-(3-甲氧基苯基)-4H-色烯; 2-氨基-3-氰基-4-(3-甲氧基苯基)-4H-咪唑并[4,5-h]色烯; 2-氨基-3-氰基-4-(3-溴-4,5-二甲氧基苯基)-4H-呋喃[2,3-h]亚甲基; 2-氨基-3-氰基-4-(3-甲氧基苯基)-4H-呋喃[2,3-h]亚甲基; 2-氨基-3-氰基-4-(3-溴-4,5-二甲氧基苯基)-4H-噻吩并[2,3-h]色烯; 2-氨基-3-氰基-4-(3-甲氧基苯基)-4H-吡唑[2,3-h]亚甲基; 2-氨基-3-氰基-4-(3-溴-4,5-二甲氧基苯基)-4H-吡唑[2,3-h]亚甲基; 2,7-二氨基-3-氰基-4-(3-碘苯基)-4H-色烯; 2,7-二氨基-3-氰基-4-(3,4,5-三甲氧基苯基)-4H-色烯; 2-氨基-3-氰基-7-羟基-4-(3,4,5-三甲氧基苯基)-4H-色烯; 2-氨基-3-氰基-7-(2-甲基丁酰基氨基)-4-(3-溴-4,5-二甲氧基苯基)-4H-色烯; 2-氨基-3-氰基-7-二甲基氨基-4-(3-(2-苯基丁酰氧基)苯基)-4H-亚甲基; 2-氨基-3-氰基-7-二甲基氨基-4-(3-(2-甲基丁酰氧基)苯基)-4H-亚甲基;和2-氨基-3-氰基-4-(3-溴-4,5-二甲氧基苯基)-4H-色烯;或其药学上可接受的盐或前药之一,以制备用于治疗对诱发其凋亡的动物敏感的疾病的药物;其中所述前药是:a)通过与C1-4羧酸,C3-6二酸或其酸酐缩合获得的含羟基化合物的酯; b)通过醛或C1-4酮的缩合获得的含氨基化合物的亚胺; c)含氨基化合物的氨基甲酸酯; d)通过与氯甲基和甲基醚或氯甲基和乙基醚缩合获得的含醇化合物的缩醛或缩酮; e)通过与磷酸酯,磷酰氯或磷酸缩合而获得的膦酸酯或膦酸酯化合物。

著录项

  • 公开/公告号ES2337558T3

    专利类型

  • 公开/公告日2010-04-27

    原文格式PDF

  • 申请/专利权人 CYTOVIA INC.;

    申请/专利号ES20020741704T

  • 申请日2002-05-16

  • 分类号C07D409;A61K31/35;A61K31/352;A61K31/38;A61K31/382;A61K31/40;A61K31/4025;A61K31/407;A61K31/415;A61K31/4188;A61K31/44;A61K31/453;A61K31/47;A61K31/495;A61K31/496;A61K31/497;A61K31/4985;A61K31/50;A61K31/505;A61K31/506;A61K31/535;A61K31/5377;A61K33/24;A61K45/06;A61P1;A61P17;A61P17/06;A61P19/02;A61P29;A61P35;A61P37/02;A61P43;C07D207;C07D209/02;C07D215/54;C07D231;C07D233/02;C07D241/36;C07D265/30;C07D311/04;C07D311/58;C07D311/64;C07D335/06;C07D401;C07D403;C07D405;C07D405/04;C07D491/04;C07D491/052;C07D493/04;C07D495/04;

  • 国家 ES

  • 入库时间 2022-08-21 18:43:06

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号